Mangrove Partners Seelos Therapeutics, Inc. Transaction History

Mangrove Partners

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.84 - $1.71 $1.79 Million - $3.65 Million	-2,133,436 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.64 - $6.32 $5.71 Million - $13.7 Million	-2,162,543 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.64 - $6.32 $5.63 Million - $13.5 Million	2,133,436 New	2,133,436 $5.63 Million
Q1 2021 May 17, 2021	BUY	$1.35 - $4.99 $2.92 Million - $10.8 Million	2,162,543 New	2,162,543 $10.8 Million

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $26.7M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Mangrove Partners, based on Form 13F filings with the SEC.

Stay updated on Mangrove Partners with notifications on news.